arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ALIGN TECHNOLOGY INC

ALGN
$148.09 ▼ -5.24 (-3.42%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
72 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
68
Health
Good
Neutral
auto_awesome

Analytical Summary

ALIGN TECHNOLOGY INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $10.6B
Dividend Yield —
Revenue Growth 4.3% ↘
Op. Margin 14.6% ↗
ROIC 2.7% ↗
FCF / Share $2.20 ↗
Trailing P/E 98.1x
Price / Book 2.5x
FCF Yield 1.5%
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

72-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.06B
↑ +4.3% —
Net Income Profit after all expenses
$108.29M
↓ -13.1% —
Operating Margin Operating profit as % of sales
14.6%
↑ +6.8% 64th
FCF / Share Free cash flow per share
$2.20
↑ +30.5% —

Health Breakdown

Profitability ↓
65
Returns ↓
68
Cash Quality ↑
73

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 19 years · 72 quarters